Table 1.

Pre and post Fe-treatment serology evaluation of the other members of the family affected with gastric neuroendocrine tumors.

Patient	II.3		II.7		II.8		II.9#x0002A;
Fe-treatment	Pre	Post	Pre	Post	Pre	Post	Pre	Post
Red blood cells [4.50–6 uL]	5.07	5.19	3.76	4.52	3.6	3.6	5.13	NT
Hemoglobin[13–17.5 g/dL]	15.3	14.9	8.9	13.5	11.3	11.3	12.5	13.7
Haematocrit [40–53%]	45.9	46.8	27.8	40.6	35.5	35.5	38.8	42
Ferritin [20–275 ng/mL]	12	54	2	NT	9	70	NT	5
Sedimentation rate [1–20 mm/hour]	13	16	35	NT	5	49	NT	33
C-reactive protein [0–0.50 mg/dL]	0.07	0.03	<0.10	NT	<0.10	0.03	NT	1.44
Fibrinogen [150–500 mg/dL]	319	349	333	NT	284	341	NT	NT
Calprotectin [ <50 ug/g]	NT	140	NT	NT	NT	246	NT	NT

NT: Not tested;

^*No Fe treatment.

Reference values are showed in brackets.